Sunesis Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Oncology
Founded
1998
Employees
51-100
Headquarters locations
South San Francisco, California, United States, North America
Social
Profile Resume
Sunesis Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Oncology sector. The company focuses on Biotechnology and has secured $31.9B in funding across 144 round(s). With a team of 51-100 employees, Sunesis Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Sunesis Pharmaceuticals, raised $43.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
9
Lead Investors
0
Total Funding Amount
$221.7M
Details
5
Sunesis Pharmaceuticals has raised a total of $221.7M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2002 | Late Stage Venture | 6.0M | ||
| 2000 | Late Stage Venture | 60.0M | ||
| 1999 | Early Stage Venture | 25.2M | ||
| 1998 | Early Stage Venture | 8.0M |
Investors
Sunesis Pharmaceuticals is funded by 46 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Vision Capital Advisors | - | FUNDING ROUND - Vision Capital Advisors | 43.5M |
| OpusPoint Partners | - | FUNDING ROUND - OpusPoint Partners | 43.5M |
| Sunesis Pharmaceuticals | - | FUNDING ROUND - Sunesis Pharmaceuticals | 43.5M |
| Nextech Invest | - | FUNDING ROUND - Nextech Invest | 43.5M |
Recent Activity
Funding Round
Oct 19, 2016
Sunesis Pharmaceuticals raised $25000000 on 2016-10-19 in Post-IPO Equity
Funding Round
Apr 01, 2016
Sunesis Pharmaceuticals raised $15000000 on 2016-04-01 in Post-IPO Debt
Funding Round
Dec 01, 2015
Sunesis Pharmaceuticals raised $25000000 on 2015-12-01 in Post-IPO Equity
Funding Round
Apr 07, 2009
Sunesis Pharmaceuticals raised $43500000 on 2009-04-07 in Post-IPO Equity
Funding Round
Sep 16, 2004
Sunesis Pharmaceuticals raised $14000000 on 2004-09-16 in Series C